Your browser doesn't support javascript.
loading
Adjuvant trastuzumab in breast cancer: experience from the University of Florence.
Livi, L; Borghesi, S; Meattini, I; Saieva, C; De Luca Cardillo, C; Scotti, V; Mangoni, M; Galardi, A; Cataliotti, L; Paiar, F; Bianchi, S; Biti, G.
Affiliation
  • Livi L; Radiotherapy Unit, University of Florence, Italy. l.livi@dfc.unifi.it
J Chemother ; 22(2): 115-8, 2010 Apr.
Article in En | MEDLINE | ID: mdl-20435571
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2010 Document type: Article Affiliation country: Italia Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2010 Document type: Article Affiliation country: Italia Country of publication: Reino Unido